The overall aim of this project is to evaluate the effectiveness, cost-effectiveness and mechanisms of action of two psychoeducational interventions: a face-to-face nurse-led intervention called FOCUS+ and an eHealth intervention called iFOCUS.…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
oncologische aandoeningen
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoints are emotional functioning and self-efficacy of both the
person with advanced cancer and the family caregiver at t1.
Secondary outcome
The secondary endpoints are: quality of life of the patient and caregiver,
benefits of illness, coping, dyadic communication, ways of giving support at
t1. All listed primary and secondary outcomes at t2 and formal healthcare use
and costs at t1 and t2
Background summary
Despite the serious problems that advanced cancer involves for patients and
their family caregivers, there are few interventions that target both the
patient and the family caregiver to self-manage these problems. Dyadic
interventions, i.e. targeting the patient and family caregiver together, are
more likely to result in better outcomes for both parties than single target
interventions and are more cost-effective.
Consequently, interventions focusing on the quality of life of both the patient
and the family caregiver (i.e. the dyad) are necessary to promote their
well-being, reduce their burden and avoid unnecessary economic costs of
end-of-life cancer care.
Study objective
The overall aim of this project is to evaluate the effectiveness,
cost-effectiveness and mechanisms of action of two psychoeducational
interventions: a face-to-face nurse-led intervention called FOCUS+ and an
eHealth intervention called iFOCUS. These interventions are aimed at improving
the emotional function and self-efficacy of patients with advanced cancer and
their family caregivers.
Specific objectives:
(1) To compare the face-to-face FOCUS+ intervention and the iFOCUS web
intervention with care as usual in terms of their:
- Effect on the emotional functioning and self-efficacy of patients with
advanced cancer and their family caregivers (primary outcomes),
- Effect on participants appraisal of the illness, uncertainty,
hopelessness, coping, dyad communication, quality of life and healthcare
resource use
- Cost-effectiveness
- Effects on vulnerable subgroups (particularly women and those with a of lower
socioeconomic status)
- Effectiveness in different healthcare systems
(2) To evaluate the implementation process of the interventions in terms of the
acceptability, feasibility, usefulness as perceived by patients, family
caregivers and healthcare staff in each country, and their mechanisms of
action.
Study design
This study is an international multicenter three-arm randomized superiority
trial.
Intervention
The face-to-face intervention: FOCUS+
Delivery mode and dose
This intervention will be provided to patient-caregiver dyads after they
completed the baseline measurement (T0) and were randomly allocated to the
face-to-face intervention. The face-to-face FOCUS+ intervention is a home-based
intervention consisting of two 90-minute home visits and one 30-minute
telephone session, conducted by a trained intervention nurse over a period of
12 weeks (4 weeks between each session).
The web-based intervention: iFOCUS
Delivery mode and dose
This intervention will be provided to patient-caregiver dyads after they
completed the baseline measurement (T0) and were randomly allocated to the web-
intervention. The web-based iFOCUS intervention is a self-managed
psycho-educational intervention that is completed autonomously by the
patient-caregiver dyads. It encompasses four sessions over a period of 12 weeks
(3 weeks between each session).
Study burden and risks
The DIAdIC protocol is non-invasive and does not involve known risks of
protocol-related injury. It is a psycho-educational intervention focused on the
provision of information; it is not intended to be a therapeutic or
cognitive/behavioral intervention.
Dr.Molewaterplein 40
Rotterdam 3015 GD
NL
Dr.Molewaterplein 40
Rotterdam 3015 GD
NL
Listed location countries
Age
Inclusion criteria
The study population will consist of patients with advanced solid organ cancer
(except brain cancer) and their primary family caregiver.
Inclusion criteria
Patient
Diagnosis of cancer: solid organ (lung, colorectal, breast, prostate and other)
No longer receives curative treatment (only life-prolonging or palliative
treatments)
Written informed consent
Lives within 100 km for intervention nurses to travel
Family caregiver
Written informed consent
Primary informal caregiver as determined by the patient
Lives within 100 km for intervention nurses to travel
Dyad
Patient and/or family caregivers has access to and is familiar with use of
internet
Exclusion criteria
Exclusion criteria
Brain cancer, brain metastases, non-solid cancers
Prognosis of less than 3 months
Has no informal caregivers
< 18 years old
Unable to participate in available languages
Family caregiver
Unable to physically or mentally participate
Cancer diagnosis in the last 12 months
<18 years old
Unable to participate in available languages
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL75241.078.20 |